All In Biotech

Free tool

FAERS Monitor: Xyzal Allergy 24hr

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209090 or its brand name (Xyzal Allergy 24hr, Levocetirizine Dihydrochloride). Reports on generic versions are filed under their own applications.

Reports

9,447

Serious

2,266

24% of reports

Hospitalization

1,001

Death reported

287

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,857
  • somnolence1,373
  • fatigue764
  • headache472
  • pruritus425
  • diarrhoea382
  • nausea377
  • dyspnoea376
  • dizziness358
  • insomnia313
  • cough303
  • therapeutic response decreased280
  • feeling abnormal272
  • arthralgia270
  • no adverse event241

Reports by year received

View as table
YearReports
20055
20065
20073
200815
200925
201018
201178
201261
201326
201433
201554
201685
2017907
20181,509
2019559
2020404
20211,649
2022914
2023837
2024836
2025855
2026569

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,712 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
somnolenceSignal1,37315.314.518,358
therapeutic response decreasedSignal28010.39.22,345
drug ineffectiveSignal1,8573.13.02,883
no adverse eventSignal2413.02.6314
insomniaSignal3132.62.3315
feeling abnormalSignal2722.52.2252
pruritusSignal4252.52.2375
coughSignal3032.42.2251
fatigueSignal7642.22.0509
headache4721.71.5132
dizziness3581.61.481
dyspnoea3761.51.359
arthralgia2701.41.337
diarrhoea3821.31.230
nausea3771.11.01

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.